WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | 咨询技术 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | Ubiquitin carboxyl-terminal hydrolase 17, USP17, Deubiquitinating enzyme 17-like protein 2, Deubiquitinating protein 3, DUB-3, Ubiquitin carboxyl-terminal hydrolase 17-like protein 2, Ubiquitin thioesterase 17-like protein 2, Ubiquitin-specific-processing protease 17-like protein 2, USP17L2 |
Entrez GeneID | 377630 |
WB Predicted band size | 59.6kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | This USP17L2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 476-503 amino acids from the C-terminal region of human USP17L2. |
Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于USP17L2抗体的3篇参考文献示例(注:文献为虚构示例,实际研究中可能需要进一步检索验证):
---
1. **文献名称**:*USP17L2 regulates innate immune response through deubiquitination of MyD88*
**作者**:Chen et al. (2020)
**摘要**:本研究利用特异性USP17L2抗体,发现其通过去泛素化MyD88调控TLR信号通路,影响巨噬细胞的炎症因子释放,为自身免疫疾病治疗提供潜在靶点。
2. **文献名称**:*Characterization of a novel monoclonal antibody against human USP17L2 for cancer biomarker discovery*
**作者**:Smith et al. (2018)
**摘要**:团队开发了针对USP17L2的单克隆抗体,验证其在高通量免疫组化中的特异性,并发现USP17L2在肺癌组织中异常高表达,可能与肿瘤增殖相关。
3. **文献名称**:*USP17L2 modulates cell cycle progression by stabilizing cyclin D1*
**作者**:Wang et al. (2021)
**摘要**:通过USP17L2抗体介导的蛋白质免疫沉淀实验,证实其通过去泛素化稳定cyclin D1蛋白,促进G1/S期转换,提示其在癌症治疗中的意义。
---
**提示**:实际文献需通过PubMed、Web of Science等平台以“USP17L2 antibody”或“USP17L2 + deubiquitinase”为关键词检索,并注意基因别名(如USP17-like protein 2)。部分研究可能聚焦于USP17家族,需结合实验目的筛选。
×